Novel Approaches to Accessing Secondary Metabolites
Novel Approaches to Accessing Secondary Metabolites
批准号:
7080410
负责人:
Losee Lucy Ling
金额:
$49.98万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-07-01 至 2007-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The overall goal of this project is to develop novel therapeutic agents against Yersinia pestis, the causative agent of plague and one of the most dangerous potential bioweapons. In this exploratory project, we will develop novel approaches to obtain previously inaccessible secondary metabolites from actinomycetes. These organisms have traditionally served as the main source for antibiotics. Recent whole genome sequencing of two well-studied streptomycete species revealed potential additional modules for synthesis of antibiotics. This agrees well with previous data from the literature indicating that the majority of antibiotics are not expressed under in vitro growth conditions. It is reasonable to assume that antibiotics are expressed in a natural environment, where they provide a competitive advantage to the producing organism. Our overall approach is to emulate the natural environment to elicit production of antibiotics. We will develop two elicitation methods in this project. According to our preliminary data, there is a particular type of compounds that emulate a critical aspect of the environment and act as antibiotic elicitors. A detailed examination of the ability of these substances to elicit production of previously unknown antibiotics will be performed with a panel of known actinomycetes. Another method of antibiotic elicitation will be based on culturing microorganisms in their natural environment, soil, in a diffusion chamber that we have previously used to grow "unculturable" microorganisms (Kaeberlein, T., Lewis, K., and Epstein, S.S. (2002) Science 296:1127-1129). Finding new compounds with antimicrobial activity from known organisms using elicitation will constitute proof of principle for the proposed approach. The methods we develop will allow for large-scale screening and validation in Phase II which will lead to the development of a new anti-Y. pestis therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Preclinical development of Novo29, a new antibiotic
-
批准号:9914205
-
项目类别:
-
资助金额:$98.74万
-
财政年份:2018
-
负责人:Losee Lucy Ling
-
依托单位:
UV-Based Approach for Accessing New Antibiotics
-
批准号:8469820
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2012
-
负责人:Losee Lucy Ling
-
依托单位:
UV-Based Approach for Accessing New Antibiotics
-
批准号:8314495
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2012
-
负责人:Losee Lucy Ling
-
依托单位:
Isolating novel actinomycetes for antibiotic discovery
-
批准号:7480833
-
项目类别:
-
资助金额:$29.9万
-
财政年份:2008
-
负责人:Losee Lucy Ling
-
依托单位:
Isolating novel actinomycetes for antibiotic discovery
-
批准号:8049200
-
项目类别:
-
资助金额:$99.96万
-
财政年份:2008
-
负责人:Losee Lucy Ling
-
依托单位:
Isolating novel fungi for antibiotic discovery
-
批准号:7340521
-
项目类别:
-
资助金额:$29.93万
-
财政年份:2007
-
负责人:Losee Lucy Ling
-
依托单位:
Isolating novel fungi for antibiotic discovery
-
批准号:8000799
-
项目类别:
-
资助金额:$99.94万
-
财政年份:2007
-
负责人:Losee Lucy Ling
-
依托单位:
Isolating novel fungi for antibiotic discovery
-
批准号:8081762
-
项目类别:
-
资助金额:$99.98万
-
财政年份:2007
-
负责人:Losee Lucy Ling
-
依托单位:
Isolating novel fungi for antibiotic discovery
-
批准号:8288280
-
项目类别:
-
资助金额:$99.93万
-
财政年份:2007
-
负责人:Losee Lucy Ling
-
依托单位:
Novel Antibiotics from Unculturable Actinomycetes
-
批准号:6998676
-
项目类别:
-
资助金额:$93.29万
-
财政年份:2005
-
负责人:Losee Lucy Ling
-
依托单位:
Developing Novel Antibiotics Against Yersinia pestis
-
批准号:7108156
-
项目类别:
-
资助金额:$179.57万
-
财政年份:2004
-
负责人:Losee Lucy Ling
-
依托单位:
Developing Novel Antibiotics Against Yersinia pestis
-
批准号:6910752
-
项目类别:
-
资助金额:$30.47万
-
财政年份:2004
-
负责人:Losee Lucy Ling
-
依托单位:
Developing Novel Antibiotics Against Yersinia pestis
-
批准号:7458045
-
项目类别:
-
资助金额:$180.58万
-
财政年份:2004
-
负责人:Losee Lucy Ling
-
依托单位:
Developing Novel Antibiotics Against Yersinia pestis
-
批准号:6833874
-
项目类别:
-
资助金额:$23.31万
-
财政年份:2004
-
负责人:Losee Lucy Ling
-
依托单位:
Developing Novel Antibiotics Against Yersinia pestis
-
批准号:7228847
-
项目类别:
-
资助金额:$181.13万
-
财政年份:2004
-
负责人:Losee Lucy Ling
-
依托单位:
H PYLORI/HUMAN PROTEIN INTERACTIONS IN GASTRIC CANCER
-
批准号:2009445
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1997
-
负责人:Losee Lucy Ling
-
依托单位:
海外基金